By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Royalty Pharma 

110 East 59th Street
33rd Floor
New York  New York  10022  U.S.A.
Phone: (212)-883-0200 Fax: (212)-883-2260



Company News
Royalty Pharma Announces Greg Norden Joins Investment Committee 1/15/2015 10:41:43 AM
Royalty Pharma Buys Royalties On Vertex Pharmaceuticals Incorporated (VRTX) Drugs For $3.3 Billion 11/19/2014 5:47:18 AM
Royalty Pharma Smacks Down $510 Million For Additional Interest In Biogen Idec, Inc. (Massachusetts) (BIIB)'s TECFIDERA® 1/6/2014 6:43:43 AM
Game May Not be Over for Royalty Pharma's Bid for Elan Corporation PLC (ELN) 6/28/2013 7:25:07 AM
Royalty Pharma Hostile Bid for Elan Corporation PLC (ELN) in Doubt After Vote 6/17/2013 7:51:25 AM
Elan Corporation PLC (ELN) Boss Martin Faces Ownership Showdown, Elan Risks Losing $2 Billion if Royalty Pharma Walks 6/13/2013 8:17:41 AM
Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan Corporation PLC (ELN) 6/11/2013 9:34:47 AM
Elan Corporation PLC (ELN) Board Rejects $6.7 Billion Royalty Pharma Offer 6/11/2013 7:17:38 AM
Royalty Pharma Raises Bid for Elan Corporation PLC (ELN) to Potential $8 Billion 6/7/2013 7:10:55 AM
Elan Corporation PLC (ELN) Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer 6/3/2013 10:31:40 AM